These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 28263965)

  • 21. Potential mechanisms linking SIRT activity and hypoxic 2-hydroxyglutarate generation: no role for direct enzyme (de)acetylation.
    Nadtochiy SM; Wang YT; Zhang J; Nehrke K; Schafer X; Welle K; Ghaemmaghami S; Munger J; Brookes PS
    Biochem J; 2017 Aug; 474(16):2829-2839. PubMed ID: 28673962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of D- and L-2-Hydroxyglutarate in Drosophila melanogaster Tissue Samples Using Gas Chromatography-Mass Spectrometry.
    Li H; Tennessen JM
    Methods Mol Biol; 2019; 1978():155-165. PubMed ID: 31119662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isocitrate dehydrogenase mutation as a therapeutic target in gliomas.
    Han CH; Batchelor TT
    Chin Clin Oncol; 2017 Jun; 6(3):33. PubMed ID: 28705010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical characterization of human D-2-hydroxyglutarate dehydrogenase and two disease related variants reveals the molecular cause of D-2-hydroxyglutaric aciduria.
    Toplak M; Brunner J; Schmidt J; Macheroux P
    Biochim Biophys Acta Proteins Proteom; 2019 Nov; 1867(11):140255. PubMed ID: 31349060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal oncometabolite L-2-hydroxyglutarate imposes a block in kidney tubulogenesis: Evidence for an epigenetic basis for the L-2HG-induced impairment of differentiation.
    Taub M; Mahmoudzadeh NH; Tennessen JM; Sudarshan S
    Front Endocrinol (Lausanne); 2022; 13():932286. PubMed ID: 36133305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomas.
    Delahousse J; Verlingue L; Broutin S; Legoupil C; Touat M; Doucet L; Ammari S; Lacroix L; Ducreux M; Scoazec JY; Malka D; Paci A; Hollebecque A
    Eur J Cancer; 2018 Feb; 90():83-91. PubMed ID: 29274619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitive Determination of Onco-metabolites of D- and L-2-hydroxyglutarate Enantiomers by Chiral Derivatization Combined with Liquid Chromatography/Mass Spectrometry Analysis.
    Cheng QY; Xiong J; Huang W; Ma Q; Ci W; Feng YQ; Yuan BF
    Sci Rep; 2015 Oct; 5():15217. PubMed ID: 26458332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of 2-hydroxyglutarate in formalin-fixed paraffin-embedded glioma specimens by gas chromatography/mass spectrometry.
    Sahm F; Capper D; Pusch S; Balss J; Koch A; Langhans CD; Okun JG; von Deimling A
    Brain Pathol; 2012 Jan; 22(1):26-31. PubMed ID: 21631627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-ketoglutarate is the precursor of L-2-hydroxyglutarate.
    Brunengraber H
    J Inherit Metab Dis; 2007 Oct; 30(5):628. PubMed ID: 17891475
    [No Abstract]   [Full Text] [Related]  

  • 30. The two enantiomers of 2-hydroxyglutarate differentially regulate cytotoxic T cell function.
    Foskolou IP; Cunha PP; Sánchez-López E; Minogue EA; Nicolet BP; Guislain A; Jorgensen C; Kostidis S; Zandhuis ND; Barbieri L; Bargiela D; Nathanael D; Tyrakis PA; Palazon A; Giera M; Wolkers MC; Johnson RS
    Cell Rep; 2023 Sep; 42(9):113013. PubMed ID: 37632752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2-hydroxyglutarate rides the cancer-immunity cycle.
    Foskolou IP; Bunse L; Van den Bossche J
    Curr Opin Biotechnol; 2023 Oct; 83():102976. PubMed ID: 37515937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Teleological role of L-2-hydroxyglutarate dehydrogenase in the kidney.
    Brinkley G; Nam H; Shim E; Kirkman R; Kundu A; Karki S; Heidarian Y; Tennessen JM; Liu J; Locasale JW; Guo T; Wei S; Gordetsky J; Johnson-Pais TL; Absher D; Rakheja D; Challa AK; Sudarshan S
    Dis Model Mech; 2020 Nov; 13(11):. PubMed ID: 32928875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase.
    Kalinina J; Ahn J; Devi NS; Wang L; Li Y; Olson JJ; Glantz M; Smith T; Kim EL; Giese A; Jensen RL; Chen CC; Carter BS; Mao H; He M; Van Meir EG
    Clin Cancer Res; 2016 Dec; 22(24):6256-6265. PubMed ID: 27340277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. d-2-Hydroxyglutarate dehydrogenase plays a dual role in l-serine biosynthesis and d-malate utilization in the bacterium
    Guo X; Zhang M; Cao M; Zhang W; Kang Z; Xu P; Ma C; Gao C
    J Biol Chem; 2018 Oct; 293(40):15513-15523. PubMed ID: 30131334
    [No Abstract]   [Full Text] [Related]  

  • 35. Resolving Challenges in Detection and Quantification of D-2-hydroxyglutarate and L-2-hydroxyglutarate via LC/MS.
    Dowdy T; Larion M
    bioRxiv; 2024 Apr; ():. PubMed ID: 38903117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling.
    Fu X; Chin RM; Vergnes L; Hwang H; Deng G; Xing Y; Pai MY; Li S; Ta L; Fazlollahi F; Chen C; Prins RM; Teitell MA; Nathanson DA; Lai A; Faull KF; Jiang M; Clarke SG; Cloughesy TF; Graeber TG; Braas D; Christofk HR; Jung ME; Reue K; Huang J
    Cell Metab; 2015 Sep; 22(3):508-15. PubMed ID: 26190651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular-endothelial response to IDH1 mutant fibrosarcoma secretome and metabolite: implications on cancer microenvironment.
    Mao MJ; Leonardi DE
    Am J Cancer Res; 2019; 9(1):122-133. PubMed ID: 30755816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncometabolite D-2-Hydroxyglurate Directly Induces Epithelial-Mesenchymal Transition and is Associated with Distant Metastasis in Colorectal Cancer.
    Colvin H; Nishida N; Konno M; Haraguchi N; Takahashi H; Nishimura J; Hata T; Kawamoto K; Asai A; Tsunekuni K; Koseki J; Mizushima T; Satoh T; Doki Y; Mori M; Ishii H
    Sci Rep; 2016 Nov; 6():36289. PubMed ID: 27824159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased glutarate production by blocking the glutaryl-CoA dehydrogenation pathway and a catabolic pathway involving L-2-hydroxyglutarate.
    Zhang M; Gao C; Guo X; Guo S; Kang Z; Xiao D; Yan J; Tao F; Zhang W; Dong W; Liu P; Yang C; Ma C; Xu P
    Nat Commun; 2018 May; 9(1):2114. PubMed ID: 29844506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [L-2-hydroxyglutaric aciduria, an error of metabolism].
    Van Schaftingen E
    Bull Mem Acad R Med Belg; 2007; 162(10-12):451-6; discussion 456-7. PubMed ID: 18557388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.